Literature DB >> 26850413

Impact of Collaborative Care for Underserved Patients with PTSD in Primary Care: a Randomized Controlled Trial.

Lisa S Meredith1,2, David P Eisenman3,4, Bing Han3, Bonnie L Green5, Stacey Kaltman5, Eunice C Wong3, Melony Sorbero6, Christine Vaughan3, Andrea Cassells7, Douglas Zatzick8, Claudia Diaz9, Scot Hickey3, Jeremy R Kurz10, Jonathan N Tobin7,11,12.   

Abstract

BACKGROUND: The effectiveness of collaborative care of mental health problems is clear for depression and growing but mixed for anxiety disorders, including posttraumatic stress disorder (PTSD). We know little about whether collaborative care can be effective in settings that serve low-income patients such as Federally Qualified Health Centers (FQHCs).
OBJECTIVE: We compared the effectiveness of minimally enhanced usual care (MEU) versus collaborative care for PTSD with a care manager (PCM).
DESIGN: This was a multi-site patient randomized controlled trial of PTSD care improvement over 1 year. PARTICIPANTS: We recruited and enrolled 404 patients in six FQHCs from June 2010 to October 2012. Patients were eligible if they had a primary care appointment, no obvious physical or cognitive obstacles to participation, were age 18-65 years, planned to continue care at the study location for 1 year, and met criteria for a past month diagnosis of PTSD. MAIN MEASURES: The main outcomes were PTSD diagnosis and symptom severity (range, 0-136) based on the Clinician-Administered PTSD Scale (CAPS). Secondary outcomes were medication and counseling for mental health problems, and health-related quality of life assessed at baseline, 6 months, and 12 months. KEY
RESULTS: Patients in both conditions improved similarly over the 1-year evaluation period. At 12 months, PTSD diagnoses had an absolute decrease of 56.7% for PCM patients and 60.6% for MEU patients. PTSD symptoms decreased by 26.8 and 24.2 points, respectively. MEU and PCM patients also did not differ in process of care outcomes or health-related quality of life. Patients who actually engaged in care management had mental health care visits that were 14% higher (p < 0.01) and mental health medication prescription rates that were 15.2% higher (p < 0.01) than patients with no engagement.
CONCLUSIONS: A minimally enhanced usual care intervention was similarly effective as collaborative care for patients in FQHCs.

Entities:  

Keywords:  PTSD; community based interventions; medicaid; mental health; primary care

Mesh:

Year:  2016        PMID: 26850413      PMCID: PMC4835392          DOI: 10.1007/s11606-016-3588-3

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  43 in total

1.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

2.  An abbreviated PTSD checklist for use as a screening instrument in primary care.

Authors:  Ariel J Lang; Murray B Stein
Journal:  Behav Res Ther       Date:  2005-05

3.  Access to specialty care and medical services in community health centers.

Authors:  Nakela L Cook; LeRoi S Hicks; A James O'Malley; Thomas Keegan; Edward Guadagnoli; Bruce E Landon
Journal:  Health Aff (Millwood)       Date:  2007 Sep-Oct       Impact factor: 6.301

4.  Integrating primary care into community behavioral health settings: programs and early implementation experiences.

Authors:  Deborah M Scharf; Nicole K Eberhart; Nicole Schmidt; Christine A Vaughan; Trina Dutta; Harold Alan Pincus; M Audrey Burnam
Journal:  Psychiatr Serv       Date:  2013-07-01       Impact factor: 3.084

5.  Assessing psychiatric impairment in primary care with the Sheehan Disability Scale.

Authors:  A C Leon; M Olfson; L Portera; L Farber; D V Sheehan
Journal:  Int J Psychiatry Med       Date:  1997       Impact factor: 1.210

6.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

Review 7.  Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD).

Authors:  Sarah E Hetrick; Rosemary Purcell; Belinda Garner; Ruth Parslow
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

8.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

9.  Posttraumatic stress disorder and treatment seeking in a national screening sample.

Authors:  Karestan C Koenen; Renee Goodwin; Elmer Struening; Fred Hellman; Mary Guardino
Journal:  J Trauma Stress       Date:  2003-02

10.  RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial.

Authors:  Paula P Schnurr; Matthew J Friedman; Thomas E Oxman; Allen J Dietrich; Mark W Smith; Brian Shiner; Elizabeth Forshay; Jiang Gui; Veronica Thurston
Journal:  J Gen Intern Med       Date:  2012-08-03       Impact factor: 5.128

View more
  14 in total

Review 1.  PTSD as a Public Mental Health Priority.

Authors:  Patricia Watson
Journal:  Curr Psychiatry Rep       Date:  2019-06-26       Impact factor: 5.285

Review 2.  The Prevalence of Posttraumatic Stress Disorder in Primary Care: A Systematic Review.

Authors:  Margaret Spottswood; Dimitry S Davydow; Hsiang Huang
Journal:  Harv Rev Psychiatry       Date:  2017 Jul/Aug       Impact factor: 3.732

Review 3.  Treatments of Posttraumatic Stress Disorder in Civilian Populations.

Authors:  Lana Ruvolo Grasser; Arash Javanbakht
Journal:  Curr Psychiatry Rep       Date:  2019-02-08       Impact factor: 5.285

4.  Capsule Commentary on Meredith et al., Impact of Collaborative Care for Underserved Patients with PTSD in Primary Care: A Randomized Controlled Trial.

Authors:  Kurt Kroenke
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

Review 5.  The Role of Integrated Primary Care in Increasing Access to Effective Psychotherapies in the Veterans Health Administration.

Authors:  Kyle Possemato; Robyn L Shepardson; Jennifer S Funderburk
Journal:  Focus (Am Psychiatr Publ)       Date:  2018-10-18

6.  Treatment of depression and PTSD in primary care clinics serving uninsured low-income mostly Latina/o immigrants: A naturalistic prospective evaluation.

Authors:  Stacey Kaltman; Maria Rosa Watson; Marcela Campoli; Adriana Serrano; Nicholas Talisman; Laura Kirkpatrick; Mihriye Mete; Bonnie L Green
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2019-02-28

7.  A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.

Authors:  Joseph Antonelli; Bing Han; Matthew Cefalu
Journal:  Stat Med       Date:  2017-08-18       Impact factor: 2.373

8.  Collaborative Care for Depression and Posttraumatic Stress Disorder: Evaluation of Collaborative Care Fidelity on Symptom Trajectories and Outcomes.

Authors:  Bradley E Belsher; Daniel P Evatt; Xian Liu; Michael C Freed; Charles C Engel; Erin H Beech; Lisa H Jaycox
Journal:  J Gen Intern Med       Date:  2018-04-27       Impact factor: 5.128

9.  Trauma-informed Collaborative Care for African American Primary Care Patients in Federally Qualified Health Centers: A Pilot Randomized Trial.

Authors:  Lisa S Meredith; Eunice Wong; Karen Chan Osilla; Margaret Sanders; Mahlet G Tebeka; Bing Han; Stephanie L Williamson; Thomas W Carton
Journal:  Med Care       Date:  2022-03-01       Impact factor: 2.983

10.  Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.

Authors:  Lisa S Meredith; Miriam S Komaromy; Matthew Cefalu; Cristina Murray-Krezan; Kimberly Page; Karen Chan Osilla; Alex R Dopp; Isabel Leamon; Lina Tarhuni; Grace Hindmarch; Vanessa Jacobsohn; Katherine E Watkins
Journal:  Contemp Clin Trials       Date:  2021-03-10       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.